Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the Philippines: a Randomized, Double-blind, Active-controlled Phase III
Latest Information Update: 30 Jan 2025
At a glance
- Drugs Varicella zoster virus vaccine Sinovac (Dalian) Vaccine Technology (Primary)
- Indications Varicella zoster virus infections
- Focus Pharmacodynamics
- Sponsors Sinovac (Dalian) Vaccine Technology
Most Recent Events
- 27 Jan 2025 Status changed from recruiting to completed.
- 04 Jun 2024 Planned End Date changed from 15 Jun 2024 to 15 Aug 2024.
- 04 Jun 2024 Planned primary completion date changed from 15 May 2024 to 15 Aug 2024.